Citation Impact
Citing Papers
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Induction of Cardiac Angptl4 by Dietary Fatty Acids Is Mediated by Peroxisome Proliferator-Activated Receptor β/δ and Protects Against Fatty Acid–Induced Oxidative Stress
2010
Molecular imaging of hypoxia with radiolabelled agents
2009
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
2008
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Diabetes or peroxisome proliferator-activated receptor α agonist increases mitochondrial thioesterase I activity in heart
2007
Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death
2006
Clinical Applications of Positron Emission Tomography in Cardiology: A Review
2004
Why do cancers have high aerobic glycolysis?
2004 Standout
In Vivo Evaluation and Small-Animal PET/CT of a Prostate Cancer Mouse Model Using 64Cu Bombesin Analogs: Side-by-Side Comparison of the CB-TE2A and DOTA Chelation Systems
2007
Ceramides in insulin resistance and lipotoxicity
2005
CARNITINE PALMITOYL TRANSFERASE‐I INHIBITION IS NOT ASSOCIATED WITH CARDIAC HYPERTROPHY IN RATS FED A HIGH‐FAT DIET
2006
Targeting hypoxia in cancer therapy
2011 Standout
Cu–ATSM: A radiopharmaceutical for the PET imaging of hypoxia
2007
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart
2007
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
2011 Standout
Cushing's syndrome
2015 Standout
Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin
2006
Comparison of Molecular Markers of Hypoxia and Imaging with 60Cu-ATSM in Cancer of the Uterine Cervix
2007
Production and Applications of Copper-64 Radiopharmaceuticals
2004
Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia
2001
Tumor detection using folate receptor-targeted imaging agents
2008
Pemetrexed Improves Tumor Selectivity of 111In-DTPA-Folate in Mice with Folate Receptor–Positive Ovarian Cancer
2008
Selection of boron reagents for Suzuki–Miyaura coupling
2013 Standout
Role of diet and fuel overabundance in the development and progression of heart failure
2008
Catalysis for fluorination and trifluoromethylation
2011 StandoutNature
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Principles of bioactive lipid signalling: lessons from sphingolipids
2008 Standout
Increased Myocardial Fatty Acid Metabolism in Patients With Type 1 Diabetes Mellitus
2006
Roles of PPARs on regulating myocardial energy and lipid homeostasis
2007
A simple Cu-64 production and its application of Cu-64 ATSM
2009
Multigenerational effects of perfluorooctanoic acid on lipid metabolism of Caenorhabditis elegans and its potential mechanism
2019
In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor–Expressing Prostate Cancer
2011
Imaging oxygenation of human tumours
2006
Microenvironmental and cellular consequences of altered blood flow in tumours
2003
Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease
2008
Bifunctional chelators for copper radiopharmaceuticals: the synthesis of [Cu(ATSM)–amino acid] and [Cu(ATSM)–octreotide] conjugates
2006
High purity production and potential applications of copper-60 and copper-61
1999
Inflammation and insulin resistance
2006 Standout
Enzymatic assembly of carbon–carbon bonds via iron-catalysed sp3 C–H functionalization
2018 StandoutNatureNobel
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Fatty acid transport proteins, implications in physiology and disease
2011
Acetylacetonate bis(thiosemicarbazone) complexes of copper and nickel: towards new copper radiopharmaceuticals
2004
Regulation of cancer cell metabolism
2011 Standout
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Alterations in energy metabolism in cardiomyopathies
2007
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Luminescent metal–organic frameworks
2009 Standout
Imaging Myocardial Metabolic Remodeling
2010
Real-Time Noninvasive Imaging of Fatty Acid Uptake in Vivo
2012 StandoutNobel
Radiometallated peptides for molecular imaging and targeted therapy
2011
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
2006
A practical guide to the construction of radiometallated bioconjugates for positron emission tomography
2011
Copper Chelation Chemistry and its Role in Copper Radiopharmaceuticals
2006
Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals
2011
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
2003
Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals
2008
Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents
2005
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Effects of chronic activation of peroxisome proliferator-activated receptor-α or high-fat feeding in a rat infarct model of heart failure
2005
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: Relationship to therapeutic response—a preliminary report
2003
Evaluation of rapid dual-tracer62Cu-PTSM +62Cu-ATSM PET in dogs with spontaneously occurring tumors
2007
MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-releasing Peptide Receptor
2006
Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET
2005
Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics
2005
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
2006
Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction
2006
Design of targeting ligands in medicinal inorganic chemistry
2006
True radiotracers: Cu-64 targeting vectors based upon bombesin peptide
2009
Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart
2006
The ABC transporter structure and mechanism: perspectives on recent research
2004
Prognostic significance of tumor oxygenation in humans
2003
Cardiac Remodeling in Obesity
2008
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Basic characterization of 64Cu-ATSM as a radiotherapy agent
2005
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
2010
Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM
2005
Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent Cu-diacetyl-bis(N 4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells
2001
Intra-tumoral distribution of 64Cu-ATSM: a comparison study with FDG
2003
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4
2013 StandoutNobel
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Studies on the Mechanism of Hypoxic Selectivity in Copper Bis(Thiosemicarbazone) Radiopharmaceuticals
2002
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
In Vitro and In Vivo Evaluation of Bifunctional Bisthiosemicarbazone 64Cu-Complexes for the Positron Emission Tomography Imaging of Hypoxia
2008
Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging.
2002
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
1999 Standout
18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
2006
Molecular Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors in Mice Using64Cu- and86Y-DOTA−(Pro1,Tyr4)-Bombesin(1−14)
2007
Chemoselective Bromodeboronation of Organotrifluoroborates Using Tetrabutylammonium Tribromide: Application in (Z)-Dibromoalkene Syntheses
2010
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Catalytic Asymmetric Arylation of α-Aryl-α-diazoacetates with Aniline Derivatives
2015
Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
2003
A Critical Role for Eukaryotic Elongation Factor 1A-1 in Lipotoxic Cell Death
2005
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Structural trends in copper(ii ) bis(thiosemicarbazone) radiopharmaceuticals
2003
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Acyclic Chelate with Ideal Properties for 68Ga PET Imaging Agent Elaboration
2010
Low Carbohydrate/High-Fat Diet Attenuates Cardiac Hypertrophy, Remodeling, and Altered Gene Expression in Hypertension
2006
Rodent models of diabetic cardiomyopathy
2009
Synthesis, Copper(II) Complexation,64Cu-Labeling, and Bioconjugation of a New Bis(2-pyridylmethyl) Derivative of 1,4,7-Triazacyclononane
2008
A “Click Chemistry” Approach to the Efficient Synthesis of Multiple Imaging Probes Derived from a Single Precursor
2009
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
2004
Synthesis, Characterization and In Vivo Studies of Cu(II)-64-Labeled Cross-Bridged Tetraazamacrocycle-amide Complexes as Models of Peptide Conjugate Imaging Agents
2007
Unconventional nuclides for radiopharmaceuticals.
2010
Synthesis and Characterization of Iodinated Tetrahydroquinolines Targeting the G Protein-Coupled Estrogen Receptor GPR30
2009
64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors.
2006
Free Fatty Acids Are Independently Associated with All-Cause and Cardiovascular Mortality in Subjects with Coronary Artery Disease
2006
Oxidative Stress and Diabetic Complications
2010 Standout
Semi-remote production of [64Cu]CuCl2 and preparation of high specific activity [64Cu]Cu-ATSM for PET studies
2005
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
2006
Adiposity of the Heart*, Revisited
2006
Cardiac Energy Metabolism in Obesity
2007
Agonist−Antagonist Dilemma in Molecular Imaging: Evaluation of a Monomolecular Multimodal Imaging Agent for the Somatostatin Receptor
2007
Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
2005
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
1999
Cy3-Cy5 Covalent Heterodimers for Single-Molecule Photoswitching
2008 StandoutNobel
Unconventional Nuclides for Radiopharmaceuticals
2010
Hexadentate Bispidine Derivatives as Versatile Bifunctional Chelate Agents for Copper(II) Radioisotopes
2009
Molecular Imaging with PET
2008
Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator
2004
Mechanisms of Diabetic Complications
2013 Standout
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
2015
Functionalized Bis(thiosemicarbazonato) Complexes of Zinc and Copper: Synthetic Platforms Toward Site-Specific Radiopharmaceuticals
2006
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Copper-64-diacetyl-bis( N 4 -methylthiosemicarbazone): An agent for radiotherapy
2001
CD36 Deficiency Rescues Lipotoxic Cardiomyopathy
2007
Recipes for Creating Animal Models of Diabetic Cardiovascular Disease
2007
Novel synthesis of [18F]‐fluorobenzene and pyridinecarbohydrazide‐folates as potential PET radiopharmaceuticals
2005
GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
2005
Lanthanide induced shifts and relaxation rate enhancements
1996
Per- and polyfluoroalkyl substances in the environment
2022 StandoutScience
On the pivotal role of PPARa in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
2016 StandoutNobel
Practical production of 61Cu using natural Co target and its simple purification with a chelating resin for 61Cu-ATSM
2004
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Chemistry: Chemical con artists foil drug discovery
2014 StandoutNature
Imaging Pancreatic Cancer with a Peptide−Nanoparticle Conjugate Targeted to Normal Pancreas
2006
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
CD36 Expression Contributes to Age-Induced Cardiomyopathy in Mice
2007
Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography
2012
Radiometals for Combined Imaging and Therapy
2012
[ 64 Cu-NOTA-8-Aoc-BBN(7-14)NH 2 ] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues
2007
Iron-catalyzed arylation of α-aryl-α-diazoesters
2016
Synthesis, 18F-Labeling, and in Vitro and in Vivo Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks
2008
Physiology of Microglia
2011 Standout
Mononuclear six-coordinated Ga(III) complexes: A comprehensive survey
2008
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Evaluation of the Stability and Animal Biodistribution of Gadolinium(III) Benzylamine-Derivatized Diethylenetriaminepentaacetic Acid
1996
64Cu-Labeled Alpha-Melanocyte-Stimulating Hormone Analog for MicroPET Imaging of Melanocortin 1 Receptor Expression
2007
Works of Terry L. Sharp being referenced
Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning
2006
Evaluation of two new gadolinium chelates as contrast agents for MRI
1992
Measurement of input functions in rodents: challenges and solutions
2005
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals
2003
Time Course of Alterations in Myocardial Glucose Utilization in the Zucker Diabetic Fatty Rat with Correlation to Gene Expression of Glucose Transporters: A Small-Animal PET Investigation
2008
Comparative studies of Cu-64-ATSM and C-11-Acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats
1999
Synthesis and Biological Evaluation of [18F]Bicalutamide, 4-[76Br]Bromobicalutamide, and 4-[76Br]Bromo-thiobicalutamide as Non-Steroidal Androgens for Prostate Cancer Imaging
2007
Synthesis of an Estrogen Receptor β-Selective Radioligand: 5-[18F]Fluoro-(2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentanenitrile and Comparison of in Vivo Distribution with 16α-[18F]Fluoro-17β-estradiol
2005
MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model
2002
Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
2002
MicroPET Imaging of a Gastrin-Releasing Peptide Receptor-Positive Tumor in a Mouse Model of Human Prostate Cancer Using a 64Cu-Labeled Bombesin Analogue
2003
Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
2002
Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.
2001
Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
2006
Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy
2004